Christiana Care part of group making   $55M bid for Hahnemann’s 550+  residency slots


Wilmington-based Christiana Care was part of a consortium of health care systems that made an apparently successful $55 million bid for Hahnemann University Hospital’s more than 550 residency slots.

The auction took place in U.S. Bankruptcy Court in Wilmington. The Philadelphia hospital no longer has patients and is winding down operations.

The six local health systems were Philadelphia-based Einstein Healthcare Network, Jefferson Health, Temple University Health System Main Line Health andCooper University Health Care in Camden as wellas Christiana Care.

Christiana Care, Delaware’s largest health care system and Jefferson have a long-running alliance, with Jefferson viewed as Delaware’s medical school. Christiana Care has hospitals in Wilmington and south of Newark.

Jefferson noted in a release that U.S. Bankruptcy Court will review the bid during a hearing scheduled for Aug. 19. Should the court approve, the transaction will provide vital medical malpractice insurance for displaced residents, which will protect them from personal liability.

Jefferson reported the coalition has been working since last month to assist in what’s been called a medical crisis for the Philadelphia region by:

  • Offering positions to 384 of approximately 570 orphaned residents;
  • Holding job fairs for nurses, physicians, and other allied health professionals;
  • Expediting credentialing processes for displaced physicians and other care providers, and
  • Increasing staffing across sites of care to ensure safe and effective care delivery.

WHYY reported Hahnemann’s owner had earlier reached a deal tto sell its residency slots for $7.5 million to Tower Health. Tower has a half a dozen area hospitals in Philadelphia suburbs, Chestnut Hill, and Reading.

Tower was then outbid during an auction process Thursday.

The Centers for Medicaid and Medicare Services funds the residency positions and has formally objected to the sale of the programs.

Whether CMS’s objection will prevent the deal from going through will be determined in U.S. Bankruptcy Court in Wilmington.

Facebook Comments